Fungal Vascular Graft Infections, French Multicenter Retrospective Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
Fungal vascular graft and endograft infections (VGEIs) are rare but life-threatening infections. Best therapeutic management is unknown. This study retrospectively gathers fungal VGEIs from 12 university hospital centers in France over a 10 year's period in order to describe their epidemiology, clinical features, therapeutic management and outcomes. Focusing on Candida spp. VGEIs, we aim to determine prognosis factors associated with therapeutic management
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged ≥ 18 years old with diagnosis of vascular graft and endograft infections (VGEI) in accordance to MAGIC criteria with diagnosis of proven invasive fungal infection according to EORTC criteria.
No opposition to re-use data.
Disqualifiers
Patient previously treated for fungal VGEI
Patient with suspected VGEI diagnosis based solely on prosthesis implantation in an infected site
Poor understanding of French.
Patient under legal protection.
Trial population
Patients with fungal infection on a vascular sample
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
epidemiology and medical treatment strategies
Other interventionAnalysis of the epidemiology and medical and surgical treatment strategies for fungal IPEV in France between January 2013 and January 2023
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Rate of mortality
Rate of all-cause mortality
Time frame
Year 1Secondary outcomes
1
Rate of mortality
Rate of all-cause mortality
Time frame
Month 12
Fungal vascular graft and endograft infections-related mortality
Fungal vascular graft and endograft infections-related mortality
Time frame
Month 1, Year 13
Rate of cure
Rate of cure, defined as : alive and without therapeutic failure (non-control of infection requiring repeat surgery or modification of anti-infective treatment)
Time frame
Year 14
Rate of sequelae
Rate of sequelae
Time frame
Year 1Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: